The global market for Structural Heart Disease Interventional Device was valued at US$ 97800 million in the year 2024 and is projected to reach a revised size of US$ 312220 million by 2031, growing at a CAGR of 18.3% during the forecast period.

Structural Heart Disease Interventional Device Market

North American market for Structural Heart Disease Interventional Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Structural Heart Disease Interventional Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Structural Heart Disease Interventional Device include Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic, Terumo, B. Braun, Lepu Medical, Koninklijke Philips NV, Biosensors International, Meril Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Structural Heart Disease Interventional Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Structural Heart Disease Interventional Device.

The Structural Heart Disease Interventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Structural Heart Disease Interventional Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Structural Heart Disease Interventional Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Structural Heart Disease Interventional Device Market Report

Report Metric	Details
Report Name	Structural Heart Disease Interventional Device Market
Accounted market size in year	US$ 97800 million
Forecasted market size in 2031	US$ 312220 million
CAGR	18.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Percutaneous Interventional Devices Thoracotomy Instruments
Segment by Application	Congenital Heart Disease Valvular Disease Cardiomyopathy Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic, Terumo, B. Braun, Lepu Medical, Koninklijke Philips NV, Biosensors International, Meril Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Structural Heart Disease Interventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Structural Heart Disease Interventional Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Structural Heart Disease Interventional Device Market growing?

Ans: The Structural Heart Disease Interventional Device Market witnessing a CAGR of 18.3% during the forecast period 2025-2031.

What is the Structural Heart Disease Interventional Device Market size in 2031?

Ans: The Structural Heart Disease Interventional Device Market size in 2031 will be US$ 312220 million.

Who are the main players in the Structural Heart Disease Interventional Device Market report?

Ans: The main players in the Structural Heart Disease Interventional Device Market are Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic, Terumo, B. Braun, Lepu Medical, Koninklijke Philips NV, Biosensors International, Meril Life Sciences

What are the Application segmentation covered in the Structural Heart Disease Interventional Device Market report?

Ans: The Applications covered in the Structural Heart Disease Interventional Device Market report are Congenital Heart Disease, Valvular Disease, Cardiomyopathy, Others

What are the Type segmentation covered in the Structural Heart Disease Interventional Device Market report?

Ans: The Types covered in the Structural Heart Disease Interventional Device Market report are Percutaneous Interventional Devices, Thoracotomy Instruments

1 Structural Heart Disease Interventional Device Market Overview

1.1 Product Definition

1.2 Structural Heart Disease Interventional Device by Type

1.2.1 Global Structural Heart Disease Interventional Device Market Value Comparison by Type (2024 VS 2031)

1.2.2 Percutaneous Interventional Devices

1.2.3 Thoracotomy Instruments

1.3 Structural Heart Disease Interventional Device by Application

1.3.1 Global Structural Heart Disease Interventional Device Market Value by Application (2024 VS 2031)

1.3.2 Congenital Heart Disease

1.3.3 Valvular Disease

1.3.4 Cardiomyopathy

1.3.5 Others

1.4 Global Structural Heart Disease Interventional Device Market Size Estimates and Forecasts

1.4.1 Global Structural Heart Disease Interventional Device Revenue 2020-2031

1.4.2 Global Structural Heart Disease Interventional Device Sales 2020-2031

1.4.3 Global Structural Heart Disease Interventional Device Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Structural Heart Disease Interventional Device Market Competition by Manufacturers

2.1 Global Structural Heart Disease Interventional Device Sales Market Share by Manufacturers (2020-2025)

2.2 Global Structural Heart Disease Interventional Device Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Structural Heart Disease Interventional Device Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Structural Heart Disease Interventional Device, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Structural Heart Disease Interventional Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Structural Heart Disease Interventional Device, Product Type & Application

2.7 Global Key Manufacturers of Structural Heart Disease Interventional Device, Date of Enter into This Industry

2.8 Global Structural Heart Disease Interventional Device Market Competitive Situation and Trends

2.8.1 Global Structural Heart Disease Interventional Device Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Structural Heart Disease Interventional Device Players Market Share by Revenue

2.8.3 Global Structural Heart Disease Interventional Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Structural Heart Disease Interventional Device Market Scenario by Region

3.1 Global Structural Heart Disease Interventional Device Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Structural Heart Disease Interventional Device Sales by Region: 2020-2031

3.2.1 Global Structural Heart Disease Interventional Device Sales by Region: 2020-2025

3.2.2 Global Structural Heart Disease Interventional Device Sales by Region: 2026-2031

3.3 Global Structural Heart Disease Interventional Device Revenue by Region: 2020-2031

3.3.1 Global Structural Heart Disease Interventional Device Revenue by Region: 2020-2025

3.3.2 Global Structural Heart Disease Interventional Device Revenue by Region: 2026-2031

3.4 North America Structural Heart Disease Interventional Device Market Facts & Figures by Country

3.4.1 North America Structural Heart Disease Interventional Device Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Structural Heart Disease Interventional Device Sales by Country (2020-2031)

3.4.3 North America Structural Heart Disease Interventional Device Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Structural Heart Disease Interventional Device Market Facts & Figures by Country

3.5.1 Europe Structural Heart Disease Interventional Device Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Structural Heart Disease Interventional Device Sales by Country (2020-2031)

3.5.3 Europe Structural Heart Disease Interventional Device Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Structural Heart Disease Interventional Device Market Facts & Figures by Region

3.6.1 Asia Pacific Structural Heart Disease Interventional Device Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Structural Heart Disease Interventional Device Sales by Region (2020-2031)

3.6.3 Asia Pacific Structural Heart Disease Interventional Device Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Structural Heart Disease Interventional Device Market Facts & Figures by Country

3.7.1 Latin America Structural Heart Disease Interventional Device Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Structural Heart Disease Interventional Device Sales by Country (2020-2031)

3.7.3 Latin America Structural Heart Disease Interventional Device Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Structural Heart Disease Interventional Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Structural Heart Disease Interventional Device Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Structural Heart Disease Interventional Device Sales by Country (2020-2031)

3.8.3 Middle East and Africa Structural Heart Disease Interventional Device Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Structural Heart Disease Interventional Device Sales by Type (2020-2031)

4.1.1 Global Structural Heart Disease Interventional Device Sales by Type (2020-2025)

4.1.2 Global Structural Heart Disease Interventional Device Sales by Type (2026-2031)

4.1.3 Global Structural Heart Disease Interventional Device Sales Market Share by Type (2020-2031)

4.2 Global Structural Heart Disease Interventional Device Revenue by Type (2020-2031)

4.2.1 Global Structural Heart Disease Interventional Device Revenue by Type (2020-2025)

4.2.2 Global Structural Heart Disease Interventional Device Revenue by Type (2026-2031)

4.2.3 Global Structural Heart Disease Interventional Device Revenue Market Share by Type (2020-2031)

4.3 Global Structural Heart Disease Interventional Device Price by Type (2020-2031)

5 Segment by Application

5.1 Global Structural Heart Disease Interventional Device Sales by Application (2020-2031)

5.1.1 Global Structural Heart Disease Interventional Device Sales by Application (2020-2025)

5.1.2 Global Structural Heart Disease Interventional Device Sales by Application (2026-2031)

5.1.3 Global Structural Heart Disease Interventional Device Sales Market Share by Application (2020-2031)

5.2 Global Structural Heart Disease Interventional Device Revenue by Application (2020-2031)

5.2.1 Global Structural Heart Disease Interventional Device Revenue by Application (2020-2025)

5.2.2 Global Structural Heart Disease Interventional Device Revenue by Application (2026-2031)

5.2.3 Global Structural Heart Disease Interventional Device Revenue Market Share by Application (2020-2031)

5.3 Global Structural Heart Disease Interventional Device Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Company Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abbott Laboratories Structural Heart Disease Interventional Device Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Boston Scientific

6.2.1 Boston Scientific Company Information

6.2.2 Boston Scientific Description and Business Overview

6.2.3 Boston Scientific Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Boston Scientific Structural Heart Disease Interventional Device Product Portfolio

6.2.5 Boston Scientific Recent Developments/Updates

6.3 Edwards Lifesciences

6.3.1 Edwards Lifesciences Company Information

6.3.2 Edwards Lifesciences Description and Business Overview

6.3.3 Edwards Lifesciences Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Edwards Lifesciences Structural Heart Disease Interventional Device Product Portfolio

6.3.5 Edwards Lifesciences Recent Developments/Updates

6.4 Medtronic

6.4.1 Medtronic Company Information

6.4.2 Medtronic Description and Business Overview

6.4.3 Medtronic Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Medtronic Structural Heart Disease Interventional Device Product Portfolio

6.4.5 Medtronic Recent Developments/Updates

6.5 Terumo

6.5.1 Terumo Company Information

6.5.2 Terumo Description and Business Overview

6.5.3 Terumo Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Terumo Structural Heart Disease Interventional Device Product Portfolio

6.5.5 Terumo Recent Developments/Updates

6.6 B. Braun

6.6.1 B. Braun Company Information

6.6.2 B. Braun Description and Business Overview

6.6.3 B. Braun Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.6.4 B. Braun Structural Heart Disease Interventional Device Product Portfolio

6.6.5 B. Braun Recent Developments/Updates

6.7 Lepu Medical

6.7.1 Lepu Medical Company Information

6.7.2 Lepu Medical Description and Business Overview

6.7.3 Lepu Medical Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Lepu Medical Structural Heart Disease Interventional Device Product Portfolio

6.7.5 Lepu Medical Recent Developments/Updates

6.8 Koninklijke Philips NV

6.8.1 Koninklijke Philips NV Company Information

6.8.2 Koninklijke Philips NV Description and Business Overview

6.8.3 Koninklijke Philips NV Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Koninklijke Philips NV Structural Heart Disease Interventional Device Product Portfolio

6.8.5 Koninklijke Philips NV Recent Developments/Updates

6.9 Biosensors International

6.9.1 Biosensors International Company Information

6.9.2 Biosensors International Description and Business Overview

6.9.3 Biosensors International Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Biosensors International Structural Heart Disease Interventional Device Product Portfolio

6.9.5 Biosensors International Recent Developments/Updates

6.10 Meril Life Sciences

6.10.1 Meril Life Sciences Company Information

6.10.2 Meril Life Sciences Description and Business Overview

6.10.3 Meril Life Sciences Structural Heart Disease Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Meril Life Sciences Structural Heart Disease Interventional Device Product Portfolio

6.10.5 Meril Life Sciences Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Structural Heart Disease Interventional Device Industry Chain Analysis

7.2 Structural Heart Disease Interventional Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Structural Heart Disease Interventional Device Production Mode & Process Analysis

7.4 Structural Heart Disease Interventional Device Sales and Marketing

7.4.1 Structural Heart Disease Interventional Device Sales Channels

7.4.2 Structural Heart Disease Interventional Device Distributors

7.5 Structural Heart Disease Interventional Device Customer Analysis

8 Structural Heart Disease Interventional Device Market Dynamics

8.1 Structural Heart Disease Interventional Device Industry Trends

8.2 Structural Heart Disease Interventional Device Market Drivers

8.3 Structural Heart Disease Interventional Device Market Challenges

8.4 Structural Heart Disease Interventional Device Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Koninklijke Philips NV

Biosensors International

Meril Life Sciences

List of Tables

Table 1. Global Structural Heart Disease Interventional Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Structural Heart Disease Interventional Device Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Structural Heart Disease Interventional Device Market Competitive Situation by Manufacturers in 2024

Table 4. Global Structural Heart Disease Interventional Device Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Structural Heart Disease Interventional Device Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Structural Heart Disease Interventional Device Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Structural Heart Disease Interventional Device Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Structural Heart Disease Interventional Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Structural Heart Disease Interventional Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Structural Heart Disease Interventional Device, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Structural Heart Disease Interventional Device, Product Type & Application

Table 12. Global Key Manufacturers of Structural Heart Disease Interventional Device, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Structural Heart Disease Interventional Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Structural Heart Disease Interventional Device as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Structural Heart Disease Interventional Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Structural Heart Disease Interventional Device Sales by Region (2020-2025) & (K Units)

Table 18. Global Structural Heart Disease Interventional Device Sales Market Share by Region (2020-2025)

Table 19. Global Structural Heart Disease Interventional Device Sales by Region (2026-2031) & (K Units)

Table 20. Global Structural Heart Disease Interventional Device Sales Market Share by Region (2026-2031)

Table 21. Global Structural Heart Disease Interventional Device Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Structural Heart Disease Interventional Device Revenue Market Share by Region (2020-2025)

Table 23. Global Structural Heart Disease Interventional Device Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Structural Heart Disease Interventional Device Revenue Market Share by Region (2026-2031)

Table 25. North America Structural Heart Disease Interventional Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Structural Heart Disease Interventional Device Sales by Country (2020-2025) & (K Units)

Table 27. North America Structural Heart Disease Interventional Device Sales by Country (2026-2031) & (K Units)

Table 28. North America Structural Heart Disease Interventional Device Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Structural Heart Disease Interventional Device Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Structural Heart Disease Interventional Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Structural Heart Disease Interventional Device Sales by Country (2020-2025) & (K Units)

Table 32. Europe Structural Heart Disease Interventional Device Sales by Country (2026-2031) & (K Units)

Table 33. Europe Structural Heart Disease Interventional Device Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Structural Heart Disease Interventional Device Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Structural Heart Disease Interventional Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Structural Heart Disease Interventional Device Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Structural Heart Disease Interventional Device Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Structural Heart Disease Interventional Device Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Structural Heart Disease Interventional Device Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Structural Heart Disease Interventional Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Structural Heart Disease Interventional Device Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Structural Heart Disease Interventional Device Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Structural Heart Disease Interventional Device Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Structural Heart Disease Interventional Device Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Structural Heart Disease Interventional Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Structural Heart Disease Interventional Device Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Structural Heart Disease Interventional Device Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Structural Heart Disease Interventional Device Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Structural Heart Disease Interventional Device Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Structural Heart Disease Interventional Device Sales (K Units) by Type (2020-2025)

Table 51. Global Structural Heart Disease Interventional Device Sales (K Units) by Type (2026-2031)

Table 52. Global Structural Heart Disease Interventional Device Sales Market Share by Type (2020-2025)

Table 53. Global Structural Heart Disease Interventional Device Sales Market Share by Type (2026-2031)

Table 54. Global Structural Heart Disease Interventional Device Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Structural Heart Disease Interventional Device Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Structural Heart Disease Interventional Device Revenue Market Share by Type (2020-2025)

Table 57. Global Structural Heart Disease Interventional Device Revenue Market Share by Type (2026-2031)

Table 58. Global Structural Heart Disease Interventional Device Price (US$/Unit) by Type (2020-2025)

Table 59. Global Structural Heart Disease Interventional Device Price (US$/Unit) by Type (2026-2031)

Table 60. Global Structural Heart Disease Interventional Device Sales (K Units) by Application (2020-2025)

Table 61. Global Structural Heart Disease Interventional Device Sales (K Units) by Application (2026-2031)

Table 62. Global Structural Heart Disease Interventional Device Sales Market Share by Application (2020-2025)

Table 63. Global Structural Heart Disease Interventional Device Sales Market Share by Application (2026-2031)

Table 64. Global Structural Heart Disease Interventional Device Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Structural Heart Disease Interventional Device Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Structural Heart Disease Interventional Device Revenue Market Share by Application (2020-2025)

Table 67. Global Structural Heart Disease Interventional Device Revenue Market Share by Application (2026-2031)

Table 68. Global Structural Heart Disease Interventional Device Price (US$/Unit) by Application (2020-2025)

Table 69. Global Structural Heart Disease Interventional Device Price (US$/Unit) by Application (2026-2031)

Table 70. Abbott Laboratories Company Information

Table 71. Abbott Laboratories Description and Business Overview

Table 72. Abbott Laboratories Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Abbott Laboratories Structural Heart Disease Interventional Device Product

Table 74. Abbott Laboratories Recent Developments/Updates

Table 75. Boston Scientific Company Information

Table 76. Boston Scientific Description and Business Overview

Table 77. Boston Scientific Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Boston Scientific Structural Heart Disease Interventional Device Product

Table 79. Boston Scientific Recent Developments/Updates

Table 80. Edwards Lifesciences Company Information

Table 81. Edwards Lifesciences Description and Business Overview

Table 82. Edwards Lifesciences Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Edwards Lifesciences Structural Heart Disease Interventional Device Product

Table 84. Edwards Lifesciences Recent Developments/Updates

Table 85. Medtronic Company Information

Table 86. Medtronic Description and Business Overview

Table 87. Medtronic Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Medtronic Structural Heart Disease Interventional Device Product

Table 89. Medtronic Recent Developments/Updates

Table 90. Terumo Company Information

Table 91. Terumo Description and Business Overview

Table 92. Terumo Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Terumo Structural Heart Disease Interventional Device Product

Table 94. Terumo Recent Developments/Updates

Table 95. B. Braun Company Information

Table 96. B. Braun Description and Business Overview

Table 97. B. Braun Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. B. Braun Structural Heart Disease Interventional Device Product

Table 99. B. Braun Recent Developments/Updates

Table 100. Lepu Medical Company Information

Table 101. Lepu Medical Description and Business Overview

Table 102. Lepu Medical Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Lepu Medical Structural Heart Disease Interventional Device Product

Table 104. Lepu Medical Recent Developments/Updates

Table 105. Koninklijke Philips NV Company Information

Table 106. Koninklijke Philips NV Description and Business Overview

Table 107. Koninklijke Philips NV Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Koninklijke Philips NV Structural Heart Disease Interventional Device Product

Table 109. Koninklijke Philips NV Recent Developments/Updates

Table 110. Biosensors International Company Information

Table 111. Biosensors International Description and Business Overview

Table 112. Biosensors International Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Biosensors International Structural Heart Disease Interventional Device Product

Table 114. Biosensors International Recent Developments/Updates

Table 115. Meril Life Sciences Company Information

Table 116. Meril Life Sciences Description and Business Overview

Table 117. Meril Life Sciences Structural Heart Disease Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Meril Life Sciences Structural Heart Disease Interventional Device Product

Table 119. Meril Life Sciences Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Structural Heart Disease Interventional Device Distributors List

Table 123. Structural Heart Disease Interventional Device Customers List

Table 124. Structural Heart Disease Interventional Device Market Trends

Table 125. Structural Heart Disease Interventional Device Market Drivers

Table 126. Structural Heart Disease Interventional Device Market Challenges

Table 127. Structural Heart Disease Interventional Device Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Structural Heart Disease Interventional Device

Figure 2. Global Structural Heart Disease Interventional Device Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Structural Heart Disease Interventional Device Market Share by Type: 2024 & 2031

Figure 4. Percutaneous Interventional Devices Product Picture

Figure 5. Thoracotomy Instruments Product Picture

Figure 6. Global Structural Heart Disease Interventional Device Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Structural Heart Disease Interventional Device Market Share by Application: 2024 & 2031

Figure 8. Congenital Heart Disease

Figure 9. Valvular Disease

Figure 10. Cardiomyopathy

Figure 11. Others

Figure 12. Global Structural Heart Disease Interventional Device Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Structural Heart Disease Interventional Device Market Size (2020-2031) & (US$ Million)

Figure 14. Global Structural Heart Disease Interventional Device Sales (2020-2031) & (K Units)

Figure 15. Global Structural Heart Disease Interventional Device Average Price (US$/Unit) & (2020-2031)

Figure 16. Structural Heart Disease Interventional Device Report Years Considered

Figure 17. Structural Heart Disease Interventional Device Sales Share by Manufacturers in 2024

Figure 18. Global Structural Heart Disease Interventional Device Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Structural Heart Disease Interventional Device Players: Market Share by Revenue in Structural Heart Disease Interventional Device in 2024

Figure 20. Structural Heart Disease Interventional Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Structural Heart Disease Interventional Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Structural Heart Disease Interventional Device Sales Market Share by Country (2020-2031)

Figure 23. North America Structural Heart Disease Interventional Device Revenue Market Share by Country (2020-2031)

Figure 24. United States Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Structural Heart Disease Interventional Device Sales Market Share by Country (2020-2031)

Figure 27. Europe Structural Heart Disease Interventional Device Revenue Market Share by Country (2020-2031)

Figure 28. Germany Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Structural Heart Disease Interventional Device Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Structural Heart Disease Interventional Device Revenue Market Share by Region (2020-2031)

Figure 35. China Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Structural Heart Disease Interventional Device Sales Market Share by Country (2020-2031)

Figure 43. Latin America Structural Heart Disease Interventional Device Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Structural Heart Disease Interventional Device Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Structural Heart Disease Interventional Device Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Structural Heart Disease Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Structural Heart Disease Interventional Device by Type (2020-2031)

Figure 53. Global Revenue Market Share of Structural Heart Disease Interventional Device by Type (2020-2031)

Figure 54. Global Structural Heart Disease Interventional Device Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Structural Heart Disease Interventional Device by Application (2020-2031)

Figure 56. Global Revenue Market Share of Structural Heart Disease Interventional Device by Application (2020-2031)

Figure 57. Global Structural Heart Disease Interventional Device Price (US$/Unit) by Application (2020-2031)

Figure 58. Structural Heart Disease Interventional Device Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Adult Artificial Heart Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32W16534

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A16598

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Inotropic Drug Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Y16200

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Retrograde Cardioplegia Cannula Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29Z16493

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions